NHLBI TOPMed: Rare Variants for Hypertension in Taiwan Chinese (THRV)

Request Access

Anthropometry (3)

BMI - Body Mass Index (phv00405791.v2.p1)
HEIGHT - Height (phv00405789.v2.p1)
WEIGHT - Weight (phv00405790.v2.p1)

Biomarkers (35)

BR - Total Bilirubin (phv00405846.v2.p1)
BUN - Blood Urea Nitrogen (phv00405847.v2.p1)
CHOL - Cholesterol (phv00405829.v2.p1)
DBP1 - 1st Diastolic Blood Pressure (phv00405796.v2.p1)
DBP2 - 2nd Diastolic Blood Pressure (phv00405798.v1.p1)
DBP3 - 3rd Diastolic Blood Pressure (phv00405800.v1.p1)
eGFR - Estimated Glomerular Giltration Rate (phv00405842.v2.p1)
GLUC - Glucose (phv00405835.v2.p1)
GOT - Glutamic Oxaloacetic Transaminase (Aspartate aminotransferase) (phv00405845.v2.p1)
GPT - Glutamic Pyruvic Transaminase (Alanine aminotransferase) (phv00405840.v2.p1)
Hb - Hemoglobin (phv00405839.v2.p1)
HbA1c - Glycated hemoglobin (phv00405836.v2.p1)
HDLC - High-Density Lipoprotein Cholesterol (phv00405831.v2.p1)
hs_CRP - High sensitive C reaction protein (phv00405849.v2.p1)
INS - Insulin (phv00405834.v2.p1)
KK - Serum Potassium (phv00405852.v2.p1)
LDLC - Low-Density Lipoprotein Cholesterol (phv00405832.v2.p1)
LDLCALC - Calculated Low-Density Lipoprotein Cholesterol (phv00405833.v2.p1)
NA - Serum Sodium (phv00426932.v1.p1)
NEU - Neutrophils (phv00405843.v2.p1)
OGTT0GLUC - Oral Glucose Tolerance Test 0 min (glucose) (phv00405817.v2.p1)
OGTT0INS - Oral Glucose Tolerance Test 0 min (insulin) (phv00405820.v2.p1)
OGTT120GLUC - Oral Glucose Tolerance Test 120 mins (glucose) (phv00405819.v2.p1)
OGTT120INS - Oral Glucose Tolerance Test 120 mins (insulin) (phv00405822.v2.p1)
OGTT60GLUC - Oral Glucose Tolerance Test 60 mins (glucose) (phv00405818.v2.p1)
OGTT60INS - Oral Glucose Tolerance Test 60 mins (insulin) (phv00405821.v2.p1)
PLCR - Plasma Creatinine (phv00405837.v2.p1)
PLT - Platelet (phv00405844.v2.p1)
PR - Pulse Rate (phv00405801.v2.p1)
SBP1 - 1st Systolic Blood Pressure (phv00405795.v2.p1)
SBP2 - 2nd Systolic Blood Pressure (phv00405797.v1.p1)
SBP3 - 3rd Systolic Blood Pressure (phv00405799.v1.p1)
TG - Triglycerides (phv00405830.v2.p1)
URIC - Uric Acid (phv00405841.v2.p1)
WBC - White Blood Cell (phv00405838.v2.p1)

Demographics (3)

AGE - Age at clinic visit (phv00405787.v1.p1)
SEX - Sex (phv00405788.v1.p1)
SEX - Sex (phv00405782.v2.p1)

Disease Events (3)

DX_DM - Diabetes Mellitus Diagnosis (phv00405806.v2.p1)
DX_HTN - Hypertension Diagnosis (phv00405804.v2.p1)
TSH - Thyroid-Stimulating Hormone (phv00405848.v2.p1)

General Health (2)

HIP - Hip Circumference (phv00405793.v2.p1)
WAIST - Waist Circumference (phv00405792.v2.p1)

Medications (7)

HTMED_AB - Anti-HT Meds: AlphaBlockers (phv00405807.v2.p1)
HTMED_ACEI - Anti-HT Meds: Angiotensin-Converting Enzyme Inhibitors (phv00405809.v2.p1)
HTMED_ARB - Anti-HT Meds: Angiotensin II Receptor Blockers (phv00405808.v2.p1)
HTMED_BB - Anti-HT Meds: BetaBlockers (phv00405810.v2.p1)
HTMED_CCB - Anti-HT Meds: Calcium Channel Blockers (phv00405811.v2.p1)
HTMED_DIURETIC - Anti-HT Meds: Diuretics (phv00405812.v2.p1)
HTMED_TOTAL - Number of Anti-Hypertensive Medications (phv00405813.v2.p1)

Study Administration (2)

DX_CAD - Coronary Artery Disease Diagnosis (phv00405805.v2.p1)
FASTING - Fasting Status (phv00405816.v2.p1)

Substance Use (1)

SMOKE - Smoke Cigarettes (phv00405802.v2.p1)

Other (34)

ALCOHOL - Drink Alcohol (phv00405803.v2.p1)
ANALYTE_TYPE - Analyte Type (phv00405855.v2.p1)
BODY_SITE - Body site where sample was collected (phv00405854.v2.p1)
CA - Serum Calcium (phv00405850.v2.p1)
CHMED_TOTAL - Number of Cholesterol Medications (phv00405815.v2.p1)
CONSENT - Consent group as determined by DAC (phv00405773.v2.p1)
DMMED_TOTAL - Number of Diabetes Medications (phv00405814.v2.p1)
FAMILY_ID - Family ID (phv00405778.v2.p1)
FATHER - Father's Subject ID (phv00405780.v2.p1)
Funding_Source - Project funding source (phv00405859.v2.p1)
IS_TUMOR - Tumor status (phv00405856.v2.p1)
MOTHER - Mother's Subject ID (phv00405781.v2.p1)
SAMPLE_ID - Sample ID (phv00405853.v2.p1)
SAMPLE_ID - Sample ID (phv00405783.v2.p1)
SEQUENCING_CENTER - Name of the center which conducted sequencing (phv00405858.v2.p1)
SOURCE_SUBJECT_ID - Subject ID used in the SUBJECT_SOURCE repository (phv00405775.v2.p1)
SOURCE_SUBJECT_ID2 - Subject ID used in the SUBJECT_SOURCE2 repository (phv00405777.v2.p1)
SSPG0 - Steady-state Plasma Glucose 0 min (phv00405823.v2.p1)
SSPG150 - Steady-state Plasma Glucose 150 mins (phv00405824.v2.p1)
SSPG160 - Steady-state Plasma Glucose 160 mins (phv00405825.v2.p1)
SSPG170 - Steady-state Plasma Glucose 170 mins (phv00405826.v2.p1)
SSPG180 - Steady-state Plasma Glucose 180 mins (phv00405827.v2.p1)
SSPGMEAN - Steady-state Plasma Glucose Mean (phv00405828.v2.p1)
Study_Name - TOPMed-assigned short study name (1:1 with TOPMed phs number) (phv00405862.v2.p1)
SUBJECT_ID - Subject Identifier (phv00405785.v1.p1)
SUBJECT_ID - Subject ID (phv00405772.v2.p1)
SUBJECT_ID - Unique Subject ID (phv00405779.v2.p1)
SUBJECT_ID - Subject ID (phv00405784.v2.p1)
SUBJECT_SOURCE - Source repository where subjects originate (phv00405786.v1.p1)
SUBJECT_SOURCE - Repository name for dbGaP study also containing this individual (phv00405774.v2.p1)
SUBJECT_SOURCE2 - Second repository name for dbGaP study also containing this individual (phv00405776.v2.p1)
TOPMed_Phase - TOPMed Phase (phv00405860.v2.p1)
TOPMed_Project - TOPMed Project that funded sequencing (phv00405861.v2.p1)
WHR - Waist Hip Ratio (phv00405794.v2.p1)